Cargando…
Apolipoprotein M - a new biomarker in sepsis
Sepsis is one of the leading causes of mortality in non-cardiac intensive care units, and the need for markers of progression and severity are high. Also, treatment of sepsis is highly debated and potential new targets of treatment are of great interest. In the previous issue of Critical Care Kumara...
Autores principales: | Christoffersen, Christina, Nielsen, Lars Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580609/ https://www.ncbi.nlm.nih.gov/pubmed/22587809 http://dx.doi.org/10.1186/cc11320 |
Ejemplares similares
-
Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes
por: Christensen, Pernille M., et al.
Publicado: (2017) -
Apolipoprotein M—A Marker or an Active Player in Type II Diabetes?
por: Christoffersen, Christina
Publicado: (2021) -
The Apolipoprotein M–Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis
por: Arkensteijn, Bas W. C., et al.
Publicado: (2013) -
PSP/reg: a new stone in sepsis biomarkers?
por: Busani, Stefano, et al.
Publicado: (2012) -
Predicting outcome in patients with sepsis: new biomarkers for old expectations
por: Charles, Pierre-Emmanuel, et al.
Publicado: (2014)